3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
47
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Head & Neck
1
Endocrine
1
Conditions
Sarcoma
211
Bone Neoplasms
58
Breast Neoplasms
40
Neoplasms
39
Osteosarcoma
37
Lymphoma
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Gastrointestinal Stromal Tumors
31
Dendritic Cell Sarcoma, Interdigitating
31
Hodgkin Disease
29
Lymphoma, Non-Hodgkin
27
Leukemia
27
Burkitt Lymphoma
25
Melanoma
24
Brain Neoplasms
24
Multiple Myeloma
23
Leukemia, Myeloid, Acute
23
Sarcoma, Ewing
22
Recurrence
21
Lymphoma, Mantle-Cell
21
Lymphoma, Large B-Cell, Diffuse
21
Glioblastoma
21
Neuroblastoma
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large-Cell, Immunoblastic
18
Gliosarcoma
18
Sarcoma, Kaposi
17
Prostatic Neoplasms
17
Pancreatic Neoplasms
17
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Esophageal Squamous Cell Carcinoma
×
Sarcoma
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled